Immediate Impact

68 standout
Sub-graph 1 of 21

Citing Papers

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
2021 Standout
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
2021 Standout
2 intermediate papers

Works of Cheigh Js being referenced

Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
1998
"End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients.
1981

Author Peers

Author Last Decade Papers Cites
Cheigh Js 23 153 19 333 101 12 533
Stefano De Pietro 12 146 24 322 94 21 591
Kinya Hiroshige 9 109 16 345 46 24 592
Giovanni Manca Rizza 5 155 54 391 163 10 623
Kyoung Sook Park 3 84 24 283 80 24 560
Soon Bae Kim 11 204 30 285 51 24 603
Dihua Xu 11 126 20 162 127 22 642
Shigemi Chiba 24 62 18 428 152 13 625
Benoı̂t Vendrely 63 64 40 294 55 18 522
Peter A. Bluestone 13 151 54 245 61 13 534
J. Delanghe 3 103 22 115 50 23 577

All Works

Loading papers...

Rankless by CCL
2026